Roberto de la Salud Bea

Dr. Roberto de la Salud Bea


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Peptides
Verified
Journal Article
Closed access
RBRoberto de la Salud Bea
Roberto de la Salud Bea
MAMichael Ross Ascuitto
Michael Ross Ascuitto
LJLaura Elena Luque de Johnson
Laura Elena Luque de Johnson

28 June 2017 in Antibiotics
Verified
Journal Article
Open access
PDF file
RBRoberto de la Salud Bea
Roberto de la Salud Bea
APAdam F. Petraglia
Adam F. Petraglia
MAMichael R. Ascuitto
Michael R. Ascuitto
QBQuentin M. Buck
Quentin M. Buck
Seven analogs of the natural, α-helix peptides IsCT1 and IsCT2—found in the venom of scorpion Opithancatus Madagascariensis—have been synthesized and tested to compare their antibacterial and hemolytic activity against natural peptides. In general, results show that increasing hydrophobicity by substituting positions 5 and 9 of the sequences with alanine, valine, and leucine, enhances antibacterial activity. However, this also increases hemolytic activity. The analog with an increased net positive charge from +1 to +3 produces moderate bacterial growth inhibition but also has high hemolytic activity. On the other hand, the analog with a negative net charge (−1) has low antibacterial properties but also no cytotoxicity under the tested conditions, a similar result was found for five of the seven studied analogs.

1 July 2015 in Toxicon
Verified
Journal Article
Closed access
RBRoberto de la Salud Bea
Roberto de la Salud Bea
APAdam Fine Petraglia
Adam Fine Petraglia
LJLaura Elena Luque de Johnson
Laura Elena Luque de Johnson

4 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
RBRoberto de la Salud Bea
Roberto de la Salud Bea
LNLily Jean North
Lily Jean North
SHSakura Horiuchi
Sakura Horiuchi
EFElaine R. Frawley
Elaine R. Frawley
QSQian Shen
Qian Shen
The antibiotic and toxic properties for four synthetic analogs of eumenine mastoparan peptides (EMP) have been tested. These properties were compared to two natural peptides found in the venom of solitary wasps Anterhynchium flavomarginatum micado (natural peptide EMP-AF) and Eumenes rubrofemoratus (natural peptide EMP-ER), respectively. Only EMP-AF-OR showed concentration-dependent growth inhibition against all bacterial species tested. Gram positive species had MIC values of 10 μg/mL for B. subtilis and 25 μg/mL for S. aureus. Gram negative species had MIC values of 25 μg/mL for E. coli and 200 μg/mL for P. aeruginosa. Of the other tested peptides, EMP-ER-D2K2 also showed activity and inhibited growth of Bacillus subtilis in a concentration-dependent manner at 200 μg/mL. Peptide EMP-ER-OR reduced the final density of Escherichia coli and B. subtilis cultures but did not impact their growth kinetics. Peptides EMP-AF-OR, EMP-ER-OR, and EMP-ER-D2K2 showed limited antifungal activity against Candida albicans or Histoplasma capsulatum. The hemolytic activity of the analogs were moderated though reports of the natural peptides, especially EMP-AF-OR, already showed low toxicity against erythrocytes. These results are discussed in the context of the potential influence of oxidized methionine on EMP activity.

21 January 2023 in Toxicon
Verified
Journal Article
Closed access
RBRoberto de la Salud Bea
Roberto de la Salud Bea
EFElaine Frawley
Elaine Frawley
QSQian Shen
Qian Shen
SMSydney Moyo
Sydney Moyo
JTJeremy M. Thelven
Jeremy M. Thelven
LNLily North
Lily North